Selinexor, a First in Class, Nuclear Export Inhibitor for the Treatment of Advanced Malignant Peripheral Nerve Sheath Tumor

Oncologist. 2021 Apr;26(4):e710-e714. doi: 10.1002/onco.13692. Epub 2021 Feb 17.

Abstract

Malignant peripheral nerve sheath tumor (MPNST) is a highly malignant neoplasm arising from peripheral nerve or its attendant sheath and is derived from Schwann or pluripotent cells of neural crest origin. Patients with recurrent, unresectable, or advanced stage disease have limited treatment options, and current therapies are associated with little benefit. In this article, we report nine cases of MPNST treated with selinexor, an orally bioavailable, selective inhibitor of nuclear export, accompanied by tumor stabilization or regression.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Active Transport, Cell Nucleus
  • Humans
  • Hydrazines
  • Nerve Sheath Neoplasms*
  • Neurofibrosarcoma*
  • Triazoles

Substances

  • Hydrazines
  • Triazoles
  • selinexor